Eyedrops Delay, May Even Prevent, Nearsightedness Eyedrops Delay, May Even Prevent, Nearsightedness
Dilating eyedrops used daily by children can delay the onset of nearsightedness, researchers found.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 14, 2023 Category: Drugs & Pharmacology Tags: Ophthalmology News Source Type: news
Aflibercept Not for Prevention in Early Diabetic Retinopathy Aflibercept Not for Prevention in Early Diabetic Retinopathy
' Preventive treatment with anti-VEGF [such as aflibercept] for eyes with nonproliferative diabetic retinopathy generally is not a strategy that is warranted, ' says study investigator.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 9, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
FDA Approves Daprodustat, First Oral Anemia Treatment FDA Approves Daprodustat, First Oral Anemia Treatment
The US Food and Drug Administration has approved daprodustat as oral treatment for anemia in patients with chronic kidney disease and on dialysis, but not for patients who are not on dialysis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - February 2, 2023 Category: Drugs & Pharmacology Tags: Nephrology News Alert Source Type: news
Persistent Gaps in Drug Use by Patients With Type 2 Diabetes Persistent Gaps in Drug Use by Patients With Type 2 Diabetes
Continuous use of glucose-, blood pressure-, and cholesterol-lowering medications by adults with mainly type 2 diabetes declined in 2005-2019. This may explain worsening diabetes complications.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 30, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
Topical Gene Therapy Gel Heals Dystrophic EB Wounds Topical Gene Therapy Gel Heals Dystrophic EB Wounds
The first topical in vivo gene therapy to reach late-stage development heals dystrophic epidermolysis bullosa wounds, researchers report.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 26, 2023 Category: Drugs & Pharmacology Tags: Dermatology News Source Type: news
Minorities With Epilepsy Blocked From'Highest Quality of Care'Minorities With Epilepsy Blocked From'Highest Quality of Care '
Even after controlling for factors that might affect medication choice, researchers found that the odds of newer medication use was associated with race.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 25, 2023 Category: Drugs & Pharmacology Tags: Neurology & Neurosurgery News Source Type: news
Eye Check Important Before Starting Semaglutide for Diabetes Eye Check Important Before Starting Semaglutide for Diabetes
Meta-analysis finds small increased risk of retinopathy worsening after starting injectable semaglutide.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 24, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
Drugs Advertised on TV Aren't Better Than Existing Options: Study Drugs Advertised on TV Aren't Better Than Existing Options: Study
Manufacturers spend more on advertising for those less beneficial drugs than for ones that work better.WebMD Health News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 18, 2023 Category: Drugs & Pharmacology Tags: Internal Medicine News Source Type: news
Paxlovid Prescribing Concerns Seen in Practitioner Survey Paxlovid Prescribing Concerns Seen in Practitioner Survey
Evidence suggests Paxlovid can improve COVID-related outcomes, so why aren ' t more physicians, nurse practitioners, physician assistants, and pharmacists prescribing the antiviral combination.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 18, 2023 Category: Drugs & Pharmacology Tags: Infectious Diseases News Source Type: news
Metformin Monotherapy Not Always Best Start in Type 2 Diabetes Metformin Monotherapy Not Always Best Start in Type 2 Diabetes
Findings suggest that at time of type 2 diabetes diagnosis some might not benefit from metformin as first-line treatment. Dual or other therapy may be preferable.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 16, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis Two Novel JAK Inhibitors Show Promise in Ulcerative Colitis
Ritlecitinib and brepocitinib were both more effective than placebo with acceptable safety in a phase 2b study of patients with moderate to severe ulcerative colitis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 12, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Two Drug Classes Appear Effective for Gastroparesis Treatment Two Drug Classes Appear Effective for Gastroparesis Treatment
Even still, there remains an unmet need for efficacious therapies for gastroparesis.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 12, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
Strong Support to Provide DAA Therapy to All Patients With HCV Strong Support to Provide DAA Therapy to All Patients With HCV
Direct-acting antiviral therapy significantly improves liver outcomes, nonliver outcomes, and long-term survival for patients with chronic hepatitis C virus, regardless of disease stage.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 11, 2023 Category: Drugs & Pharmacology Tags: Gastroenterology News Source Type: news
PPI Use in Type 2 Diabetes Links With Cardiovascular Events PPI Use in Type 2 Diabetes Links With Cardiovascular Events
Prospective data from almost 20,000 people with type 2 diabetes show that proton pump inhibitor use is linked with significantly more cardiovascular disease events and all-cause death than nonuse.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 10, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
Latest Steps Toward Reducing US Insulin Cost Begin in 2023 Latest Steps Toward Reducing US Insulin Cost Begin in 2023
Co-pay caps for Medicare beneficiaries begin in 2023, while new federal legislation, state laws, and new insulin manufacturers all eyed as more possible solutions.Medscape Medical News (Source: Medscape Pharmacist Headlines)
Source: Medscape Pharmacist Headlines - January 6, 2023 Category: Drugs & Pharmacology Tags: Diabetes & Endocrinology News Source Type: news
